Back to results
RecruitingN/A

Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator

NCT04504188

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

TriHealth Hatton Research Institute

Cincinnati, Ohio, United States

+3 additional locations

View on ClinicalTrials.gov
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator — TrialFind